These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 8788178)

  • 21. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
    Hall JM; McDonnell DP
    Endocrinology; 1999 Dec; 140(12):5566-78. PubMed ID: 10579320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
    Diep CH; Ahrendt H; Lange CA
    Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplified Crosstalk Between Estrogen Binding and GFR Signaling Mediated Pathways of ER Activation Drives Responses in Tumors Treated with Endocrine Disruptors.
    Suba Z
    Recent Pat Anticancer Drug Discov; 2018; 13(4):428-444. PubMed ID: 30027855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens.
    Montano MM; Ekena K; Delage-Mourroux R; Chang W; Martini P; Katzenellenbogen BS
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6947-52. PubMed ID: 10359819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.
    Montano MM; Katzenellenbogen BS
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2581-6. PubMed ID: 9122238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
    Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R
    Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.
    Aronica SM; Katzenellenbogen BS
    Mol Endocrinol; 1993 Jun; 7(6):743-52. PubMed ID: 7689695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone.
    Smith CL; Conneely OM; O'Malley BW
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6120-4. PubMed ID: 8327492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a novel transferable cis element in the promoter of an estrogen-responsive gene that modulates sensitivity to hormone and antihormone.
    Montano MM; Kraus WL; Katzenellenbogen BS
    Mol Endocrinol; 1997 Mar; 11(3):330-41. PubMed ID: 9058379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence.
    Fujimoto N; Katzenellenbogen BS
    Mol Endocrinol; 1994 Mar; 8(3):296-304. PubMed ID: 7517003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
    Cho H; Katzenellenbogen BS
    Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steroid receptor action.
    Brosens JJ; Tullet J; Varshochi R; Lam EW
    Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):265-83. PubMed ID: 15157642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC; Katzenellenbogen BS
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
    Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
    Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists.
    Kraus WL; Katzenellenbogen BS
    Endocrinology; 1993 Jun; 132(6):2371-9. PubMed ID: 8504742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
    Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
    Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor isoform-specific induction of progesterone receptors in human osteoblasts.
    Rickard DJ; Waters KM; Ruesink TJ; Khosla S; Katzenellenbogen JA; Katzenellenbogen BS; Riggs BL; Spelsberg TC
    J Bone Miner Res; 2002 Apr; 17(4):580-92. PubMed ID: 11918216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor binding to estrogen response elements slows ligand dissociation and synergistically activates reporter gene expression.
    Klinge CM
    Mol Cell Endocrinol; 1999 Apr; 150(1-2):99-111. PubMed ID: 10411304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.